Pennsylvania Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04M Buy
4,204
+64
+2% +$65.4K 1.28% 17
2026
Q1
$3.81M Hold
4,140
1.09% 17
2025
Q4
$4.45M Sell
4,140
-50
-1% -$47.8K 1.22% 16
2025
Q3
$3.2M Hold
4,190
0.93% 21
2025
Q2
$3.27M Buy
4,190
+5
+0.1% +$3.88K 1.04% 19
2025
Q1
$3.46M Sell
4,185
-61
-1% -$50.8K 1.27% 15
2024
Q4
$3.28M Buy
4,246
+25
+0.6% +$20.7K 1.12% 18
2024
Q3
$3.74M Buy
4,221
+373
+10% +$335K 1.34% 16
2024
Q2
$3.48M Buy
3,848
+26
+0.7% +$20.8K 1.34% 15
2024
Q1
$2.97M Sell
3,822
-29
-0.8% -$20.6K 1.22% 16
2023
Q4
$2.24M Buy
3,851
+199
+5% +$116K 0.89% 24
2023
Q3
$1.96M Buy
3,652
+19
+0.5% +$9.79K 0.81% 23
2023
Q2
$1.7M Buy
3,633
+7
+0.2% +$2.94K 0.73% 24
2023
Q1
$1.25M Hold
3,626
0.6% 28
2022
Q4
$1.31M Hold
3,626
0.69% 31
2022
Q3
$1.17M Hold
3,626
0.65% 23
2022
Q2
$1.18M Hold
3,626
0.62% 23
2022
Q1
$1.04M Hold
3,626
0.44% 30
2021
Q4
$1M Hold
3,626
0.34% 40
2021
Q3
$884K Buy
3,626
+2,626
+263% +$648K 0.39% 35
2021
Q2
$235K Buy
+1,000
New +$201K 0.12% 64
2020
Q3
Sell
-1,330
Closed -$218K 94
2020
Q2
$218K Buy
+1,330
New +$204K 0.12% 105

Other funds holding LLY

Pennsylvania Capital Management's LLY Position: Q2 2026 in Review

Pennsylvania Capital Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $65.4K and bringing the position to 4,204 shares worth $5.04M. The position accounts for 1.28% of the portfolio, ranked #17.

Pennsylvania Capital Management first reported a position in LLY in Q2 2020 and has held it in 22 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pennsylvania Capital Management held 4,204 shares of Eli Lilly worth $5.04M as of Q2 2026.
  • Pennsylvania Capital Management bought 64 Eli Lilly shares in Q2 2026, an estimated $65.4K.
  • Eli Lilly made up 1.28% of Pennsylvania Capital Management's portfolio in Q2 2026, its #17 holding.
  • Pennsylvania Capital Management first reported a position in Eli Lilly in Q2 2020 and has held it in 22 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pennsylvania Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.